UNSPSC 51183602: Glucagon

This classification denotes a peptide hormone, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 76LA80IG2G. European Medicines Agency schedules Glucagon in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02347MIG. Glucagon generally arises in the molecular formula C153H225N43O49S. The term GLUCAGON is a European Pharmacopoeia designation. GLUCAGON is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

UNSPSC 51183602 Glucagon is a Commodity code covering pharmaceutical products being solicited by state and local procurement offices as part of coordinated purchasing alliances for hospital systems, clinics, and other public health facilities. State and local governments source glucagon through multi-source pharmaceutical procurement vehicles that bundle generics and over-the-counter products with authorized wholesaler distribution networks. Issuing bodies under this code include state purchasing departments and multistate cooperative alliances administering contracts on behalf of member state agencies and local government facilities. Minnesota's Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is a primary buyer, consolidating demand across participating jurisdictions to negotiate volume pricing and standardize supply-chain compliance.

MMCAP's January 2026 RFP for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, demonstrates current sourcing patterns under the code. The alliance distributes products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—with awarded vendors required to maintain contractual relationships with at least two of them. Evaluation emphasizes price competitiveness (75 percent weight), compliance with Good Manufacturing Practices and Drug Supply Chain Security Act certification, and administrative compliance; vendors must offer fixed pricing, net price formats (NF30, NF60, NF90), or WAC-minus structures and pay a 3 percent administrative fee on all purchases. Contract awards are effective July 1, 2026, with two-year initial terms and optional extensions. Activity under the code concentrates in multistate purchasing regions, with Minnesota and Oregon as participating jurisdictions in the MMCAP vehicle documented in current solicitations.